- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,189GBP
- Report
- February 2024
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- January 2024
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- February 2024
- 185 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1201EUR$1,250USD£1,033GBP
- Report
- May 2020
- 104 Pages
Global
From €3988EUR$4,150USD£3,429GBP
- Report
- April 2023
- 120 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- July 2021
- 111 Pages
Global
From €4564EUR$4,750USD£3,924GBP
- Report
- August 2020
- 113 Pages
Global
From €4084EUR$4,250USD£3,511GBP
- Report
- June 2021
- 50 Pages
China
From €2498EUR$2,600USD£2,148GBP
- Report
- October 2018
- 30 Pages
China
From €2114EUR$2,200USD£1,818GBP
- Report
- March 2023
- 130 Pages
Global
From €3459EUR$3,600USD£2,974GBP
- Report
- March 2023
- 64 Pages
Europe
From €1441EUR$1,500USD£1,239GBP
- Drug Pipelines
- September 2020
- 57 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Report
- May 2023
- 100 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- February 2024
- 101 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- October 2023
- 83 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- June 2022
- 53 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Drug Pipelines
- June 2020
- 65 Pages
Global
From €1922EUR$2,000USD£1,652GBP
Omeprazole is a proton pump inhibitor used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), peptic ulcer disease, and erosive esophagitis. It is also used to reduce the risk of gastric ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). Omeprazole works by blocking the enzyme in the stomach that produces acid, thus reducing the amount of acid in the stomach.
Omeprazole is available in both prescription and over-the-counter (OTC) forms. Prescription forms are typically used to treat more severe cases of GERD and other gastrointestinal disorders, while OTC forms are used to treat milder cases. Omeprazole is also available in combination with other medications, such as antibiotics, to treat more severe cases of GERD and other gastrointestinal disorders.
The market for Omeprazole is highly competitive, with many pharmaceutical companies offering their own versions of the drug. Some of the major players in the market include Pfizer, AstraZeneca, GlaxoSmithKline, Merck, and Novartis. Show Less Read more
